Company Filing History:
8 out of 4,455 
1 out of 832,887 Years Active: 2002-2010
Title: Andrew Gordon Swick: Innovator in Glucocorticoid Receptor Modulation
Introduction
Andrew Gordon Swick is a notable inventor based in East Lyme, CT (US). He has made significant contributions to the field of pharmacology, particularly in the development of glucocorticoid receptor modulators. With a total of 9 patents to his name, Swick's work has the potential to impact the treatment of various diseases.
Latest Patents
Swick's latest patents focus on non-steroidal compounds that act as selective modulators of the glucocorticoid receptor. These compounds can function as both agonists and antagonists, providing a versatile approach to therapy. The pharmaceutical compositions derived from these compounds are designed to treat conditions such as obesity, diabetes, and inflammation. Additionally, the patents detail intermediates and processes for preparing these innovative compounds.
Career Highlights
Throughout his career, Andrew Gordon Swick has worked with prominent organizations, including Pfizer Corporation. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to develop groundbreaking therapies.
Collaborations
Swick has collaborated with notable colleagues, including Bradley Paul Morgan and Robert L Dow. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Andrew Gordon Swick is a distinguished inventor whose work in glucocorticoid receptor modulation holds promise for treating various health conditions. His innovative approach and collaboration with industry leaders underscore his impact on the field of pharmacology.